ArticleBMC medical genetics2020

Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy.

Alexander Hendricks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.